TCT-76 Mid-Term Outcomes after Transcatheter Aortic Valve Replacement With a Mechanically-Expanded Versus Self-Expandable Valve: 3-Year Results From the REPRISE III Randomized Trial

REPRISE III is the first large randomized comparison of 2 TAVR platforms: the mechanically-expanded Lotus valve (Boston Scientific, Marlborough, Massachusetts) and self-expanding CoreValve (CV) (Medtronic, Dublin, Ireland). In aortic stenosis patients with high/extreme surgical risk, Lotus was